MicroRNA dysregulation in cancer: Opportunities for the development of microRNA-based drugs

IDrugs

Volumn 13, Issue 12, 2010, Pages 843-846

  Nana Sinkam, S Patrick ^a,b   Croce, Carlo M ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Biomarker; cancer; drug development; drug resistance; dysregulation; microRNA; miRNA; therapeutic

Indexed keywords

ANTAGOMIR; GAMMA INTERFERON; GEMCITABINE; LOCKED NUCLEIC ACID; MESSENGER RNA; MICRORNA; MICRORNA 155; MICRORNA 181B; MICRORNA 21; MICRORNA 221; MICRORNA 222; MICRORNA 29B; MICRORNA 34B; MICRORNA 34C; MICRORNA 449; MIRAVIRSEN; OLIGONUCLEOTIDE; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

ACUTE GRANULOCYTIC LEUKEMIA; BREAST CANCER; CANCER RESISTANCE; DRUG SENSITIVITY; GENE EXPRESSION; GENE TARGETING; GENETIC POLYMORPHISM; GENETIC REGULATION; HEMATOLOGIC MALIGNANCY; HEPATITIS C; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; LUNG NON SMALL CELL CANCER; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; OVARY CANCER; PANCREAS CANCER; PROGNOSIS; REVIEW; RNA PROCESSING; SOLID TUMOR;

ANIMALS; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, NEOPLASM; HUMANS; MICRORNAS; MOLECULAR TARGETED THERAPY; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79952754331     PISSN: 13697056     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (7)

1. Croce CM: Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet (2009) 10(10):704-714.
2. Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y, Chen Y, Xu L, Zen K, Zhang C, Shen H: Serum microRNA signatures identifed in a genome-wide serum microRNA expression profling predict survival of non-small-cell lung cancer. J Clin Oncol (2010) 28(10):1721-1726.
3. Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, van Eijndhoven MA, Hopmans ES, Lindenberg JL, de Gruijl TD, Würdinger T, Middeldorp JM: Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci USA (2010) 107(14):6328-6333.
4. Kowarsch A, Marr C, Schmidl D, Ruepp A, Theis FJ: Tissue-specifc target analysis of disease-associated microRNAs in human signaling pathways. PLoS ONE (2010) 5(6):e11154.
5. Elmén J, Lindow M, Schütz S, Lawrence M, Petri A, Obad S, Lindholm M, Hedtjärn M, Hansen HF, Berger U, Gullans S et al: LNA-mediated microRNA silencing in non-human primates. Nature (2008) 452(7189):896-899. (Pubitemid 351550859)
6. Ebert MS, Neilson JR, Sharp PA: MicroRNA sponges: Competitive inhibitors of small RNAs in mammalian cells. (2007) Nat Methods 4(9):721-726. (Pubitemid 47338166)
7. Brown BD, Naldini L: Exploiting and antagonizing microRNA regulation for therapeutic and experimental pplications. Nat Rev Genet (2009) 10(8):578-585.